Oxidative modifications of S100 proteins: functional regulation by redox - PubMed (original) (raw)
Review
Oxidative modifications of S100 proteins: functional regulation by redox
Su Yin Lim et al. J Leukoc Biol. 2009 Sep.
Abstract
Several S100 Ca(2+)-binding proteins undergo various post-translational modifications that may alter their intracellular and extracellular functions. S100A8 and S100A9, two members of this family, are particularly susceptible to oxidative modification. These proteins, abundantly expressed in neutrophils and activated macrophages, are associated with acute and chronic inflammatory conditions, including microbial infections, cystic fibrosis, rheumatoid arthritis, and atherosclerosis. They have diverse intracellular roles including NADPH oxidase activation and arachidonic acid transport and can be secreted via a Golgi-independent pathway to exert extracellular functions. Many pro-inflammatory functions have been described for S100A8 and S100A9, but they are also implicated in anti-inflammatory roles in wound-healing and protection against excessive oxidative tissue damage,the latter as a result of their exquisite capacity to scavenge oxidants. Similarly, their genes are induced by proinflammatory (LPS and TNF-alpha) stimuli, but induction is IL-10-dependent, and anti-inflammatory glucocorticoids induce or amplify expression. S100A8 and S100A9 were described recently as damage-associated molecular pattern molecules, which provide a novel, conceptual framework for understanding their functions. However, because of this designation, recent reviews focus solely on their pro-inflammatory functions. Here, we summarize the mounting evidence from functional and gene regulation studies that these proteins may also play protective roles. This review offers an explanation for the disparate, functional roles of S100A8 and S100A9 based on emerging data that post-translational, oxidative modifications may act as a regulatory switch.
Similar articles
- Inflammation-associated S100 proteins: new mechanisms that regulate function.
Goyette J, Geczy CL. Goyette J, et al. Amino Acids. 2011 Oct;41(4):821-42. doi: 10.1007/s00726-010-0528-0. Epub 2010 Mar 6. Amino Acids. 2011. PMID: 20213444 Review. - FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8.
Rahimi F, Hsu K, Endoh Y, Geczy CL. Rahimi F, et al. FEBS J. 2005 Jun;272(11):2811-27. doi: 10.1111/j.1742-4658.2005.04703.x. FEBS J. 2005. PMID: 15943814 - IL-10-dependent S100A8 gene induction in monocytes/macrophages by double-stranded RNA.
Endoh Y, Chung YM, Clark IA, Geczy CL, Hsu K. Endoh Y, et al. J Immunol. 2009 Feb 15;182(4):2258-68. doi: 10.4049/jimmunol.0802683. J Immunol. 2009. PMID: 19201880 - [Possibility of formation of the S100A8/A9-proinflammatory cytokine complexes in vivo in acute inflammation and their functional roles].
Ishihara K, Namura T, Murayama H, Arai S, Totani M, Ikemoto M. Ishihara K, et al. Rinsho Byori. 2009 Apr;57(4):324-31. Rinsho Byori. 2009. PMID: 19489433 Japanese. - S100A8 and S100A9 in inflammation and cancer.
Gebhardt C, Németh J, Angel P, Hess J. Gebhardt C, et al. Biochem Pharmacol. 2006 Nov 30;72(11):1622-31. doi: 10.1016/j.bcp.2006.05.017. Epub 2006 Jul 17. Biochem Pharmacol. 2006. PMID: 16846592 Review.
Cited by
- Functions of S100 proteins.
Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, Geczy CL. Donato R, et al. Curr Mol Med. 2013 Jan;13(1):24-57. Curr Mol Med. 2013. PMID: 22834835 Free PMC article. Review. - Calprotectin (S100A8/S100A9) and myeloperoxidase: co-regulators of formation of reactive oxygen species.
Bøyum A, Skrede KK, Myhre O, Tennfjord VA, Neurauter CG, Tolleshaug H, Knudsen E, Opstad PK, Bjørås M, Benestad HB. Bøyum A, et al. Toxins (Basel). 2010 Jan;2(1):95-115. doi: 10.3390/toxins2010095. Epub 2010 Jan 20. Toxins (Basel). 2010. PMID: 22069549 Free PMC article. - Unique mechanisms of sheng yu decoction ( shèng yù tang) on ischemic stroke mice revealed by an integrated neurofunctional and transcriptome analysis.
Hou YC, Lu CK, Wang YH, Chern CM, Liou KT, Wang HW, Shen YC. Hou YC, et al. J Tradit Complement Med. 2013 Oct;3(4):240-9. doi: 10.4103/2225-4110.119703. J Tradit Complement Med. 2013. PMID: 24716184 Free PMC article. - Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine.
Iigo M, Alexander DB, Xu J, Futakuchi M, Suzui M, Kozu T, Akasu T, Saito D, Kakizoe T, Yamauchi K, Abe F, Takase M, Sekine K, Tsuda H. Iigo M, et al. Biometals. 2014 Oct;27(5):1017-29. doi: 10.1007/s10534-014-9747-2. Epub 2014 May 28. Biometals. 2014. PMID: 24867408 Free PMC article. Clinical Trial. - Covalent small molecule inhibitors of Ca(2+)-bound S100B.
Cavalier MC, Pierce AD, Wilder PT, Alasady MJ, Hartman KG, Neau DB, Foley TL, Jadhav A, Maloney DJ, Simeonov A, Toth EA, Weber DJ. Cavalier MC, et al. Biochemistry. 2014 Oct 28;53(42):6628-40. doi: 10.1021/bi5005552. Epub 2014 Oct 14. Biochemistry. 2014. PMID: 25268459 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous